Advertisement
A live webcast of the presentation will be available online from theinvestor relations page of the Company's Web site at http://www.accuray.com.The webcast replay of the presentation will begin approximately 30 minutesafter the conclusion of the live presentation and will be available forapproximately 30 days.
Advertisement
About the CyberKnife(R) Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only roboticradiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlledrobotic mobility, the CyberKnife System automatically tracks, detects andcorrects for tumor and patient movement in real-time throughout the treatment.This enables the CyberKnife System to deliver high-dose radiation withpinpoint precision, which minimizes damage to surrounding healthy tissue andeliminates the need for invasive head or body stabilization frames.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is aglobal leader in the field of radiosurgery dedicated to providing an improvedquality of life and a non-surgical treatment option for those diagnosed withcancer. Accuray develops and markets the CyberKnife Robotic RadiosurgerySystem, which extends the benefits of radiosurgery to include extracranialtumors, including those in the spine, lung, prostate, liver and pancreas. Todate, the CyberKnife System has been used to treat more than 40,000 patientsworldwide and currently more than 130 systems have been installed in leadinghospitals in the Americas, Europe and Asia. For more information, please visithttp://www.accuray.com.
SOURCE Accuray Incorporated
